EcoGenome
Wynnewood, US · Founded 2021 · Pennsylvania LLC
Ecogenome performs molecular genetic testing of individual patients' tumors to identify therapeutic vulnerabilities and guide cancer therapy planning. The company focuses on the molecular genetics of treatment-resistant cancers.
Founders & leadership
EcoGenome was founded in 2021 by Richard G Pestell.
RG
Richard G PestellFounder
MW
Mark WallerManager of the Issuer
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2022
▶$2MraisedNov 2022 · 10 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard G PestellExecutive Officer
- Mark WallerDirector
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- May 2022
- Incorporated
- Limited Liability Company, Pennsylvania, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does EcoGenome do?
- Ecogenome performs molecular genetic testing of individual patients' tumors to identify therapeutic vulnerabilities and guide cancer therapy planning. The company focuses on the molecular genetics of treatment-resistant cancers.
- Who founded EcoGenome?
- EcoGenome was founded by Richard G Pestell in 2021.
- How much funding has EcoGenome raised?
- EcoGenome has disclosed $2M raised across 1 round.
- Where is EcoGenome headquartered?
- EcoGenome is headquartered in Wynnewood, US.